[Corrigendum] FNDC3B promotes epithelial-mesenchymal transition in tongue squamous cell carcinoma cells in a hypoxic microenvironment

• Authors:
  • Zhaoming Zhong
  • Hongxing Zhang
  • Min Hong
  • Chuanzheng Sun
  • Yuanyuan Xu
  • Xiao Chen
  • Change Gao
  • Minjie He
  • Weiqing Liu
  • Jin Liang

• View Affiliations

  
  Affiliations: Department of Medical Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China, Department of Head and Neck Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China, Department of Oncology, The First People's Hospital of Kunming, Kunming, Yunnan 650032, P.R. China
• Published online on: August 25, 2020     https://doi.org/10.3892/or.2020.7744
• Pages: 2319-2319

• Copyright : © Zhong et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Article

Oncol Rep 39: [Related article:] 1853-1859, 2018; DOI: 10.3892/or.2018.6231

During the preparation of the above article, the authors inadvertently selected an incorrect pair of data panels for Fig. 5B. Essentially, in the published version of Fig. 5B, the images were presented incorrectly for the NC migration and KD#3 migration and invasion data panels associated with the TSCCA cell Transwell assay experiments. Furthermore, in Fig. 7A, the GAPDH control bands were erroneously selected for the figure.

Figure 5. After knockdown of FNDC3B, the invasive and migratory abili- ties of (A) TCA8113 and (B) TSCCA cells were significantly decreased, as assessed by Transwell assay. *P<0.05, **P<0.01, ***P<0.001 compared to the NC-transfected cells. Photomicrographs are at ×100 magnification.

Figure 7. CoCl2 promotes EMT via inducing FNDC3B expression. (A) Western blotting of TCA8113 cells after treatment with 0.1 mM CoCl2 for 12 h using the indicated antibodies. (B) Western blotting of FNDC3B in shRNA- or NC-transfected TCA8113 cells using the indicated antibodies.

Figs. 5 and 7 as they should have appeared in the Journal are shown opposite, incorporating the correct data for Figs. 5B and 7A. These errors did not affect either the results or the conclusions of this work. The authors all agree to this Corrigendum, and thank the Editor of Oncology Reports for allowing them to have the opportunity to present their corrected data. Furthermore, the authors apologize to the readership for any inconvenience these errors may have caused.